Sanofi India Limited (BOM:500674)

Revenue by Segment

Financials in millions INR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Pharmaceutical Business	18.37B	20.13B	19.96B	27.70B	29.57B
Pharmaceutical Business Growth	-8.73%	0.86%	-27.94%	-6.31%	1.88%
Total	18.37B	20.13B	19.96B	27.70B	29.57B
Total Growth	-8.73%	0.86%	-27.94%	-6.31%	1.88%

Revenue by Geography

Financials in millions INR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
India	15.93B	16.05B	14.99B	23.42B	25.54B
India Growth	-0.74%	7.02%	-35.98%	-8.28%	11.40%
Singapore	2.31B	3.92B	3.86B	3.99B	3.88B
Singapore Growth	-41.18%	1.53%	-3.06%	2.73%	-29.58%
Others	138.00M	163.00M	1.10B	295.00M	152.00M
Others Growth	-15.34%	-85.24%	274.24%	94.08%	-74.19%
Total	18.37B	20.13B	19.96B	27.70B	29.57B
Total Growth	-8.73%	0.86%	-27.94%	-6.31%	1.88%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 15, 2026

Data Sources Report a data error